GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.
- Published In:
- Survey of ophthalmology, 68(6), 1071-1083 (2023)
- Authors:
- Kapoor, Ishani, Sarvepalli, Swara M, D'Alessio, David, Grewal, Dilraj S, Hadziahmetovic, Majda
- Database ID:
- RPEP-07028
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07028APA
Kapoor, Ishani; Sarvepalli, Swara M; D'Alessio, David; Grewal, Dilraj S; Hadziahmetovic, Majda. (2023). GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.. Survey of ophthalmology, 68(6), 1071-1083. https://doi.org/10.1016/j.survophthal.2023.07.002
MLA
Kapoor, Ishani, et al. "GLP-1 receptor agonists and diabetic retinopathy: A meta-analysis of randomized clinical trials.." Survey of ophthalmology, 2023. https://doi.org/10.1016/j.survophthal.2023.07.002
RethinkPeptides
RethinkPeptides Research Database. "GLP-1 receptor agonists and diabetic retinopathy: A meta-ana..." RPEP-07028. Retrieved from https://rethinkpeptides.com/research/kapoor-2023-glp1-receptor-agonists-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.